Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Ping An Healthcare and Technology Company ( (HK:1833) ) has issued an announcement.
Ping An Healthcare and Technology Company Limited announced the resignation of Mr. Jun Wu as an executive director and president, effective July 10, 2025, due to personal work arrangements. The company assures stakeholders that operations will remain unaffected and governance will continue to be efficient. Concurrently, Ms. Luoqi Zang has been appointed as an executive director. Ms. Zang, who joined the company in 2022, brings extensive experience in financial and operational management, having previously worked with prominent firms like PricewaterhouseCoopers and Didi Chuxing. Her appointment is expected to bolster the company’s strategic direction and operational oversight.
The most recent analyst rating on (HK:1833) stock is a Buy with a HK$12.20 price target. To see the full list of analyst forecasts on Ping An Healthcare and Technology Company stock, see the HK:1833 Stock Forecast page.
More about Ping An Healthcare and Technology Company
Ping An Healthcare and Technology Company Limited operates in the healthcare technology industry, offering digital healthcare services and solutions. The company focuses on integrating technology with healthcare to improve service delivery and efficiency.
Average Trading Volume: 10,265,610
Technical Sentiment Signal: Buy
Current Market Cap: HK$20.88B
Learn more about 1833 stock on TipRanks’ Stock Analysis page.